1. Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries. (November 2018) Authors: Kandolf Sekulovic, L.; Guo, J.; Agarwala, S.; Hauschild, A.; McArthur, G.; Cinat, G.; Wainstein, A.; Caglevic, C.; Lorigan, P.; Gogas, H.; Alvarez, M.; Duncombe, R.; Lebbe, C.; Peris, K.; Rutkowski, P.; Stratigos, A.; Forsea, A.-M.; De La Cruz Merino, L.; Kukushkina, M.; Dummer, R. Journal: European journal of cancer Issue: Volume 104(2018) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Beyond the BRAFV600E hotspot: biology and clinical implications of rare BRAF gene mutations in melanoma patients. (1st October 2017) Authors: Richtig, G.; Hoeller, C.; Kashofer, K.; Aigelsreiter, A.; Heinemann, A.; Kwong, L.N.; Pichler, M.; Richtig, E. Journal: British journal of dermatology Issue: Volume 177:Number 4(2017) Page Start: 936 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Beyond the BRAFV600E hotspot: biology and clinical implications of rare BRAF gene mutations in melanoma patients. (4th September 2017) Authors: Richtig, G.; Hoeller, C.; Kashofer, K.; Aigelsreiter, A.; Heinemann, A.; Kwong, L.N.; Pichler, M.; Richtig, E. Journal: British journal of dermatology Issue: Volume 177:Number 4(2017) Page Start: 936 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy of pembrolizumab in patients with advanced mucosal melanoma enrolled in the KEYNOTE-001, 002, and 006 studies. (February 2017) Authors: Butler, M.; Hamid, O.; Ribas, A.; Hodi, F.S.; Walpole, E.; Dauad, A.; Arance, A.; Brown, E.; Hoeller, C.; Mortier, L.; Schachter, J.; Long, J.; Ebbinghaus, S.; Ibrahim, N.; Robert, C. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Erythema nodosum‐like lesions during BRAF inhibitor therapy: Report on 16 new cases and review of the literature. (6th March 2015) Authors: Mössner, R.; Zimmer, L.; Berking, C.; Hoeller, C.; Loquai, C.; Richtig, E.; Kähler, K.C.; Hassel, J.C.; Gutzmer, R.; Ugurel, S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 9(2015:Sep.) Page Start: 1797 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL). (February 2017) Authors: Ascierto, P.; Bastholt, L.; Mohr, P.; Hoeller, C.; Robert, C.; Larkin, J.; Dummer, R.; Ekbom, A.; Chiarion-Sileni, V.; Dutriaux, C.; Mortier, L.; Neyns, B.; Nyakas, M.; Garbe, C.; Baurain, J.F.; Kruse, V.; Svane, I.M.; Alfaya, L.; Ciria, C.; Blank, C. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments. (April 2017) Authors: Kandolf Sekulovic, L.; Peris, K.; Hauschild, A.; Stratigos, A.; Grob, J.-J.; Nathan, P.; Dummer, R.; Forsea, A.-M.; Hoeller, C.; Gogas, H.; Demidov, L.; Lebbe, C.; Blank, C.; Olah, J.; Bastholt, L.; Herceg, D.; Neyns, B.; Vieira, R.; Hansson, J.; Rutkowski, P. Journal: European journal of cancer Issue: Volume 75(2017) Page Start: 313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pretherapeutic laboratory findings, extent of metastasis and choice of treatment as prognostic markers in ocular melanoma– a single centre experience. (12th October 2012) Authors: Schicher, N.; Edelhauser, G.; Harmankaya, K.; Schindler, K.; Gleiss, A.; Pehamberger, H.; Hoeller, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 27:Number 3(2013:Mar.) Page Start: e394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Talimogene laherparepvec (T‐VEC) in advanced melanoma: complete response in a heart and kidney transplant patient. A case report. (1st July 2019) Authors: Ressler, J.; Silmbrod, R.; Stepan, A.; Tuchmann, F.; Cicha, A.; Uyanik‐Ünal, K.; Hoeller, C. Journal: British journal of dermatology Issue: Volume 181:Number 1(2019) Page Start: 186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Talimogene laherparepvec (T‐VEC) in advanced melanoma: complete response in a heart and kidney transplant patient. A case report. (26th March 2019) Authors: Ressler, J.; Silmbrod, R.; Stepan, A.; Tuchmann, F.; Cicha, A.; Uyanik‐Ünal, K.; Hoeller, C. Journal: British journal of dermatology Issue: Volume 181:Number 1(2019) Page Start: 186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗